Literature DB >> 11806875

Efficacy of school urinary screening for membranoproliferative glomerulonephritis type 1.

Y Kawasaki1, J Suzuki, R Nozawa, H Suzuki.   

Abstract

AIMS: In order to evaluate the efficacy of a school urinary screening programme, children with membranoproliferative glomerulonephritis (MPGN) type 1 were studied.
METHODS: A total of 52 patients who had been diagnosed with MPGN type 1 from 1970 to 1997 were studied; 35 were identified after 1974 on screening (group S), and 17 were identified by presenting symptoms (group N), mostly before 1989.
RESULTS: Mean blood pressure was 89 mm Hg in group S and 104 mm Hg in group N; urinary protein excretion was 0.9 g/day in group S and 3.0 g/day in group N. Histopathological evidence of chronic changes was found in six group S and 15 group N patients. No patients in group S had renal insufficiency, but five patients in group N required regular haemodialysis.
CONCLUSIONS: Results suggest that early identification by school urinary screening may enable early management and so improve prognosis of MPGN.

Entities:  

Mesh:

Year:  2002        PMID: 11806875      PMCID: PMC1719067          DOI: 10.1136/adc.86.1.21

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases.

Authors:  R Habib; C Kleinknecht; M C Gubler; M Levy
Journal:  Clin Nephrol       Date:  1973 Jul-Aug       Impact factor: 0.975

2.  Schönlein-Henoch nephritis.

Authors:  S R Meadow; E F Glasgow; R H White; M W Moncrieff; J S Cameron; C S Ogg
Journal:  Q J Med       Date:  1972-07

3.  The treatment of chronic mesangiocapillary (membranoproliferative) glomerulonephritis with impaired renal function.

Authors:  P Kincaid-Smith
Journal:  Med J Aust       Date:  1972-09-09       Impact factor: 7.738

4.  [Evaluation of methylprednisolone pulse therapy in membranoproliferative glomerulonephritis].

Authors:  T Ito; O Hasegawa; H Hatsukano; H Sakaguchi
Journal:  Nihon Jinzo Gakkai Shi       Date:  1978-06

5.  Mesangiocapillary glomerulonephritis: changes in glomerular morphology with long-term alternate-day prednisone therapy.

Authors:  A J McAdams; P T McEnery; C D West
Journal:  J Pediatr       Date:  1975-01       Impact factor: 4.406

6.  The effect of prednisone in a high-dose, alternate-day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis.

Authors:  P T McEnery; A J McAdams; C D West
Journal:  Medicine (Baltimore)       Date:  1985-11       Impact factor: 1.889

7.  Idiopathic membranoproliferative (mesangiocapillary) glomerulonephritis: a clinicopathologic study.

Authors:  J V Donadio; T K Slack; K E Holley; D M Ilstrup
Journal:  Mayo Clin Proc       Date:  1979-03       Impact factor: 7.616

Review 8.  Lessons learned from the Japanese nephritis screening study.

Authors:  T Kitagawa
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

9.  Long-term prognosis of membranoproliferative glomerulonephritis type I. Significance of clinical and morphological parameters: an investigation of 220 cases.

Authors:  H Schmitt; A Bohle; T Reineke; D Mayer-Eichberger; W Vogl
Journal:  Nephron       Date:  1990       Impact factor: 2.847

10.  Idiopathic membranoproliferative glomerulonephritis in Japanese children.

Authors:  K Iitaka; T Ishidate; M Hojo; S Kuwao; N Kasai; T Sakai
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

View more
  6 in total

1.  An 11-year-old girl with antineutrophil cytoplasmic antibody-associated glomerulonephritis identified by a school urinary screening program.

Authors:  Shuto Kanno; Yukihiko Kawasaki; Ryo Maeda; Kyohei Miyazaki; Atsushi Ono; Yuichi Suzuki; Kazuhide Suyama; Shigeo Suzuki; Mitsuaki Hosoya
Journal:  CEN Case Rep       Date:  2014-05-27

2.  Long-term follow-up of atypical membranoproliferative glomerulonephritis: are steroids indicated?

Authors:  Teruo Fujita; Kandai Nozu; Kazumoto Iijima; Ichiro Kamioka; Kunihiko Yoshiya; Ryojiro Tanaka; Kiyoshi Hamahira; Koichi Nakanishi; Norishige Yoshikawa; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2005-10-25       Impact factor: 3.714

3.  Long-term follow-up of diffuse membranoproliferative glomerulonephritis type I.

Authors:  Takeshi Yanagihara; Mari Hayakawa; Junko Yoshida; Masami Tsuchiya; Toshisada Morita; Mutsumi Murakami; Yoshitaka Fukunaga
Journal:  Pediatr Nephrol       Date:  2005-03-22       Impact factor: 3.714

4.  Prognostic factors in children with membranoproliferative glomerulonephritis type I.

Authors:  Silvestre García-de la Puente; Iraida Luz Orozco-Loza; Samuel Zaltzman-Girshevich; Beatriz de Leon Bojorge
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

5.  Efficacy of urine screening at school: experience in Shanghai, China.

Authors:  Yi-Hui Zhai; Hong Xu; Guang-Hua Zhu; Min-Jiang Wei; Bing-Chun Hua; Qian Shen; Jia Rao; Jie Ge
Journal:  Pediatr Nephrol       Date:  2007-10-18       Impact factor: 3.714

6.  Differences in clinical findings, pathology, and outcomes between C3 glomerulonephritis and membranoproliferative glomerulonephritis.

Authors:  Yukihiko Kawasaki; Syuto Kanno; Atsushi Ono; Yuichi Suzuki; Shinichiro Ohara; Masatoki Sato; Kazuhide Suyama; Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Pediatr Nephrol       Date:  2016-02-04       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.